@article{SHC5586,
author = {Giulia Sedda and Roberto Gasparri and Lorenzo Spaggiari},
title = {Translational new frontiers in lung cancer research},
journal = {Shanghai Chest},
volume = {4},
number = {0},
year = {2019},
keywords = {},
abstract = {Lung cancer (LC) accounts for 1.6 million death each year, remaining the leading cause of oncology-related death. This worst-case scenario is linked to poor survival associated with late diagnosis. This happens commonly in clinical practice, even in countries with strong and developed health systems, resulting in a lower chance of survival and a higher cost of treatment. Ideally, screening in an asymptomatic at-risk population could increase the chance of recognition cancerous cells, or even pre-cancerous conditions, in a majority of individuals who will results negative to the test. With this article, we aim to summarize the best new approach in LC research.},
issn = {2521-3768}, url = {https://shc.amegroups.org/article/view/5586}
}